The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus
about
Bacteriophage lysins as effective antibacterialsBiocontrol and Rapid Detection of Food-Borne Pathogens Using Bacteriophages and EndolysinsAntimicrobial bacteriophage-derived proteins and therapeutic applicationsAntibiotic alternatives: the substitution of antibiotics in animal husbandry?Crystal structure of the lytic CHAPK domain of the endolysin LysK from Staphylococcus aureus bacteriophage KStructural and biochemical characterization reveals LysGH15 as an unprecedented "EF-hand-like" calcium-binding phage lysinThree New Escherichia coli Phages from the Human Gut Show Promising Potential for Phage TherapyBacteriophage receptor binding protein based assays for the simultaneous detection of Campylobacter jejuni and Campylobacter coli.Salmonella enterica phage-resistant mutant colonies display an unusual phenotype in the presence of phage Felix 01.Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.Preclinical safety evaluation of intravenously administered SAL200 containing the recombinant phage endolysin SAL-1 as a pharmaceutical ingredientPharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers.Staphylococcus haemolyticus prophage ΦSH2 endolysin relies on cysteine, histidine-dependent amidohydrolases/peptidases activity for lysis 'from without'A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia.A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus.Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88.LysGH15B, the SH3b domain of staphylococcal phage endolysin LysGH15, retains high affinity to staphylococci.Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogensBacteriophage endolysins as novel antimicrobials.LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection.Recombinant bacteriophage lysins as antibacterialsMechanisms of antibiotic resistance in Staphylococcus aureus.The truncated phage lysin CHAP(k) eliminates Staphylococcus aureus in the nares of miceComparison of the antibacterial properties of phage endolysins SAL-1 and LysK.Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection.Complete genome sequence of the prototype lactic acid bacterium Lactococcus lactis subsp. cremoris MG1363.Phage Therapy - Everything Old is New AgainRETRACTED: Identification of Peptidoglycan Hydrolase Constructs with Synergistic Staphylolytic Activity in Cow's Milk.Genome Analysis of Phage SMSAP5 as Candidate of Biocontrol for Staphylococcus aureus.Expression and lytic efficacy assessment of the Staphylococcus aureus phage SA4 lysin geneTriple-acting Lytic Enzyme Treatment of Drug-Resistant and Intracellular Staphylococcus aureusMolecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysinNovel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus.Bacteriophage and their lysins for elimination of infectious bacteria.Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivoCombination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia.Peptidoglycan hydrolases-potential weapons against Staphylococcus aureusThe Staphylococci phages family: an overviewViruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.Use of encapsulated bacteriophages to enhance farm to fork food safety.
P2860
Q24648457-9F0969DF-690A-408B-9D34-1DC5CA2CF8A3Q26752523-8048F466-9F76-41DE-9359-068483EC3823Q26781115-0847618A-629B-4F84-AFFC-3DA2620786B5Q27027984-4DDCF9F1-E5A7-42C4-801F-5D3388DAF854Q27684825-9953DD12-0038-4F5A-9559-4B215BBC2675Q28538904-93FDBCED-B856-47A3-9B09-0C7376E00E9CQ28550170-F7B7CA43-1AB2-4D1D-BBA3-87F08DC3548BQ31123614-EC89FEF9-D177-46B8-A9E9-00A0A1C95CEEQ33301041-196AFF03-620B-49EA-8612-568BC5D62BDBQ33525230-69116D07-6FF5-4D1C-9D65-C682F343C768Q33622902-EAD6CA88-2A6F-4600-AE3C-DEE317334836Q33726692-47A8F7EC-BD37-44B3-B05C-3F910503D151Q33775374-F29CC9FC-F1ED-4AAC-8050-5654F20A0A78Q33797903-213CF887-F953-46D2-884F-CCA8A25C3330Q33854421-D9C4CD24-BAE3-4FCC-A59F-17EE93C085FFQ33935353-9C322FE0-283E-4665-A239-7220224326DFQ34030455-DABAD54E-C6EC-4977-92B2-5234E75B5EF0Q34114172-37281731-A7DD-4846-8815-B6E69956AA33Q34303439-98D3E833-6537-434C-97D5-FE7A9E872402Q34487554-2D7F62CB-65ED-4265-8F5D-2603A1C11D3DQ34558237-B901A326-E0E8-4FC2-B632-BA120B581D28Q34657311-40744B92-A032-4880-829E-3ECE5094A4D6Q34664096-2D5003B4-BC41-426D-B447-CF1757E6FE3CQ34737900-31F4807B-F8B9-4D5B-801A-EA96E19EE373Q35432724-AB9C3A67-DED9-4486-9078-9EF1517C5C59Q35759658-5AC9BCAB-5DE3-4921-A2D3-3AD73B61F30CQ36171271-E8D49D17-3FCE-4287-B621-D77C3A067155Q36270490-2BC9BCEA-8307-405A-AF8C-EBC3266972C6Q36380286-0E63F4EB-C682-4576-B1D5-0B8A74C2905BQ36736576-E812A1FE-DD11-4591-94DC-B35BA954C2BEQ36845812-5A8D3B74-6ABA-461C-9937-BA49CBABBD0AQ36933726-17478A66-13A4-4ED1-9E3E-BB4463FB5B8FQ37026612-4658D777-2506-41F4-AD72-AE177947AC84Q37470848-C0D6CA60-3666-4F30-81DF-D969E5192E82Q37544464-8F111892-A6FE-4C97-8DC1-FDAF7B871395Q37696606-4AE4DCB7-FFFA-488B-A05E-79CCF7C3E0B4Q38053102-7C545DE2-C0EB-4BD6-98B3-3C2393A07F41Q38076134-2166358C-B209-490F-B3D4-78E8E1FD1E92Q38215724-24A13C4A-7950-4296-BC2B-75F60A0D3EE4Q38584325-F6A67B83-391C-4E4F-967B-9F2BC40186F8
P2860
The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The recombinant phage lysin Ly ...... esistant Staphylococcus aureus
@ast
The recombinant phage lysin Ly ...... esistant Staphylococcus aureus
@en
The recombinant phage lysin Ly ...... esistant Staphylococcus aureus
@nl
type
label
The recombinant phage lysin Ly ...... esistant Staphylococcus aureus
@ast
The recombinant phage lysin Ly ...... esistant Staphylococcus aureus
@en
The recombinant phage lysin Ly ...... esistant Staphylococcus aureus
@nl
prefLabel
The recombinant phage lysin Ly ...... esistant Staphylococcus aureus
@ast
The recombinant phage lysin Ly ...... esistant Staphylococcus aureus
@en
The recombinant phage lysin Ly ...... esistant Staphylococcus aureus
@nl
P2093
P2860
P1476
The recombinant phage lysin Ly ...... esistant Staphylococcus aureus
@en
P2093
Fitzgerald GF
O'Flaherty S
P2860
P304
P356
10.1128/JB.187.20.7161-7164.2005
P407
P577
2005-10-01T00:00:00Z